Journal
BRIEFINGS IN FUNCTIONAL GENOMICS
Volume 16, Issue 1, Pages 46-56Publisher
OXFORD UNIV PRESS
DOI: 10.1093/bfgp/elv053
Keywords
germ line genome editing; CRISPR/Cas9; disease prevention; assisted reproductive technology; genetic enhancement; global society
Funding
- JSPS KAKENHI [26460586]
Ask authors/readers for more resources
Genome editing allows for the versatile genetic modification of somatic cells, germ cells and embryos. In particular, CRISPR/ Cas9 is worldwide used in biomedical research. Although the first report on Cas9-mediated gene modification in human embryos focused on the prevention of a genetic disease in offspring, it raised profound ethical and social concerns over the safety of subsequent generations and the potential misuse of genome editing for human enhancement. The present article considers germ line genome editing approaches from various clinical and ethical viewpoints and explores its objectives. The risks and benefits of the following three likely objectives are assessed: the prevention of monogenic diseases, personalized assisted reproductive technology (ART) and genetic enhancement. Although genetic enhancement should be avoided, the international regulatory landscape suggests the inevitability of this misuse at ART centers. Under these circumstances, possible regulatory responses and the potential roles of public dialogue are discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available